Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease

<table>IgG anti-GP2 antibodies in 225 patients with Crohn’s disease (CD) and 225 patients with ulcerative colitis (UC). A cutoff of 20 AU/mL established by the manufacturer of the commercial ELISA (Generic Assays) is indicated with a dot line.</table>

Journal of Immunology Research

fig1

Figure 1

Figure 1: Ileal Inflammation May Trigger the Development of GP2-Specific Pancreatic Autoantibodies in Patients with Crohn’s Disease 